Reimplantation of EndoBarrier device proves safe in obesity trial

04/30/2012 | MassDevice.com (Boston)

GI Dynamics' EndoBarrier gastrointestinal sleeve can be reimplanted in obese patients who have previously been treated with the device without complications, according to a 19-patient study. The findings were presented at the 5th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders in Barcelona, Spain.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN